About: European Medicines Agency
Vaccine hesitancy creates concern in the fight against COVID-19
Scepticism about adverse effects and actual lack of efficacy in immunisation practices can become an important negative factor when a vaccine against coronavirus becomes available, according to the head of the EU's medicines agency (EMA), Guido Rasi.
Europe dodges US fentanyl crisis but for how long?
When 18-year-old Joseph bought a pill at a fun fair in the French Riviera resort of Cannes, he was convinced it was morphine.
MEP: EU framework on medical cannabis to give ‘peace of mind’ to patients
A strong EU regulatory framework on medical cannabis is needed to provide investors with stability but also to give peace of mind to patients struggling with fragmented legislation among member states, socialist MEP Miriam Dalli said.
Europe gives go ahead to market Ebola vaccine
The European Union authorised the marketing of a vaccine against Ebola on Monday (11 November), permitting the first wider commercial use of a protection that has helped stem an outbreak in DR Congo.
Brexit turns EU into landlord in the City of London
The European Medicines Agency is looking to sublet its former headquarters in the financial district of London, after a British court ruled on Wednesday (20 February) that it cannot break its lease despite the UK’s withdrawal from the EU.
Clogs gift for EU medicines agency’s Brexit move
Dutch officials handed over a pair of clogs and the keys to the European Medicines Agency's temporary base in Amsterdam on Wednesday (9 January) as the watchdog prepares to leave London after Brexit.
European Medicines Agency launches review of recalled heart drug
The European Medicines Agency (EMA) said Thursday it is conducting a review of the health effects on patients of a widely used blood pressure medication recalled around the world last month.
EU drugs agency to see 30% staff losses over Brexit move
The European Medicines Agency (EMA) is to scale back operations further as it copes with higher than expected staff losses, triggered by the watchdog's forced relocation from London to Amsterdam because of Brexit.
Health care risks being forgotten in Brexit talks, industry warns
Health risks being forgotten in Brexit negotiations, potentially delaying the availability of new medicines and imposing large costs on manufacturers, public health leaders have warned.
Italian pharma chief: Dutch EMA bid ‘may have misled’ the Commission
The smooth transition of the EU drug agency from London to Amsterdam is threatened by delays in the Netherlands, whose bid to win the agency may have been misleading, a top representative of Italian pharmaceuticals told EURACTIV.com.
Dutch official: The EU drug agency transition has been ‘by the book’
The preparations for relocating the European Medicines Agency to the Netherlands next year are underway and on schedule, a senior Dutch government official in the EU told EURACTIV.com on Wednesday (31 January), after recent media reports suggested that Italy wants to appeal to the EU Court.
Italy cries foul over temporary accommodation of EU Medicines Agency
Dutch officials and the head of the European Medicines Agency (EMA) sought yesterday (29 January) to allay any jitters among the agency's 900 London-based staff who are being asked to move to Amsterdam because of Britain's departure from the EU.
No deal ‘uniquely damaging’ to health sector, warns UK minister
Failing to reach a Brexit deal for the medical sector would be “uniquely damaging” to both the UK and EU, UK Health Secretary Jeremy Hunt told MPs on Tuesday (23 January).
Stakeholders call for more transparent meetings between pharma and EMA
Public health organisations and EU lawmakers say the closed-door meetings before the submission of a new drug between the pharma industry and the European Medicines Agency (EMA), a key player in the continent’s healthcare industry, should be more transparent.
Pharma firms face multi-million Brexit bill, MPs warned
Pharmaceutical companies face a multi-million euro bill in regulatory costs regardless of whether the UK reaches a ‘soft’ or ‘hard’ Brexit deal with the European Union, industry leaders warned on Tuesday (19 December).
Access to clinical trials and innovative treatments at risk after Brexit
LONDON: Patients in Britain risk delays to access life-saving medicines if the UK deviates from EU regulatory standards post-Brexit, a leading medical representative has warned.
Amsterdam, Paris take EU agencies in lucky dip thriller
Amsterdam and Paris won the right to host the two EU agencies that must leave London on Brexit after a dramatic ministerial meeting in Brussels on Monday (20 November) that left both result decided by drawing lots after votes were tied.
On Rome visit, Borissov lashes out at ‘passive’ EU diplomacy
In a visit to Rome yesterday (14 November) Bulgarian Prime Minister Boyko Borissov praised his host Paolo Gentiloni for stopping refugees from Libya, and lashed out at EU’s diplomacy, which is led by another Italian, Federica Mogherini.
Fate of banking, medicines agencies to be decided by secret ballot
EU ministers will vote by secret ballot on the relocation of two EU agencies currently based in London at the General Affairs Council on 20 November. The ballot papers will then be destroyed and no record kept.
Slovakia a pro-European island in its region, Fico says
Slovakia's prime minister, president and parliament speaker pledged yesterday (23 October) to keep to a pro-European path, a day after its Czech neighbours became the latest central European ex-Communists to elect a populist taking a hard line on the EU.
EU agency OK’d 39 cancer drugs without evidence they work, study shows
The European Medicines Agency approved 39 new cancer drugs between 2009 and 2013 despite having no evidence that they worked, unnecessarily exposing patients to toxicity, researchers said Thursday (5 October).
Croatia minister on EMA: ‘Moral’ obligation to favour a country without EU agency
In assessing the relocation of the EU drugs agency EMA, old member states have a "moral and political obligation" to give an advantage to those candidate countries that do not currently host another EU agency, Croatia’s health minister told EURACTIV.com.
Europe’s south in discussions to form an alliance ahead of EMA vote
The Southern EU member states are exploring the possibility of forming a united camp regarding the relocation of the European Medicines Agency from London after Brexit, Greece’s Deputy Foreign Minister George Katrougalos said.